Surgical soft tissue forceps market seen reaching $1.93 billion by 2030

The surgical soft tissue forceps market is projected to grow from $1.38 billion in 2025 to $1.48 billion in 2026, according to The Business Research Company. Demand is being fueled by more aesthetic and minimally invasive surgeries, with North America holding the largest regional share in 2025.

Why it matters: - Surgical soft tissue forceps are becoming more important as surgeons perform more delicate procedures that require precision, tissue control and lower trauma. - The market’s growth reflects broader expansion in surgical volume, outpatient care and infection-control priorities. - The report points to a $1.92 billion opportunity as the market scales through the decade.

What happened: - The Business Research Company released a report on the surgical soft tissue forceps market on Aug. 31, 2026. - The market is projected to rise from $1.38 billion in 2025 to $1.48 billion in 2026, a 7.5% CAGR. - The market is forecast to reach $1.93 billion by 2030, growing at a 6.8% CAGR. - North America held the largest share of the global market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - Surgical soft tissue forceps are precision tools used to grasp, hold and manipulate delicate soft tissues during surgery. - The tools are designed to limit injury, improve accuracy and reduce trauma. - Recent market growth has been linked to more surgical procedures, expanding hospital infrastructure, wider access to advanced surgical tools, stronger focus on patient safety and more use of minimally invasive techniques. - Future growth is expected to be supported by demand for disposable surgical instruments, stronger infection control, more outpatient surgeries, advanced instrument coatings and higher healthcare spending on surgical devices. - Key market trends include greater demand for precision instruments, a shift toward single-use forceps, ergonomic design improvements, corrosion-resistant materials and sterility-focused product development. - Aesthetic surgery is a major demand driver because soft tissue forceps help surgeons handle tissue carefully in procedures such as facelifts, rhinoplasties and breast augmentations. - The International Society of Aesthetic Plastic Surgery reported nearly 38 million aesthetic procedures globally in 2024, including 17.4 million surgical and 20.5 million non-surgical procedures. - Minimally invasive surgery is also pushing demand because these procedures use smaller incisions and specialized tools to reduce tissue damage. - The American Society of Plastic Surgeons reported a 7% increase in minimally invasive procedures in the U.S. between 2022 and 2023. - North America’s lead is tied to advanced healthcare infrastructure, high adoption of innovative surgical techniques and substantial healthcare spending. - The report says its 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and future trend analysis. - The report offers a free sample and full report online: Download the free sample and View the full report.

Between the lines: - The market is benefiting from two durable shifts: more cosmetic procedures and more surgery delivered through minimally invasive methods. - Single-use and infection-control trends suggest buyers are prioritizing safety and workflow efficiency over instrument reuse. - North America’s lead suggests mature health systems are adopting these tools fastest, but the report’s regional coverage points to broader global expansion ahead.

What's next: - The market is expected to keep expanding through 2030 as outpatient surgery, disposable instruments and advanced coatings gain share. - Product development is likely to focus on precision, ergonomics, corrosion resistance and sterility. - The report positions the segment for continued demand as surgical volumes increase worldwide.